Projects Funded This Year

From February 2001 to December 2022, The Morgan Adams Foundation has provided nearly $9 million in research “seed funding” for novel bench science studies. That funding has enabled an additional $17 million in partnership and follow on grants.




“The crucial support from Morgan Adams continues to fund all those high-risk, high-reward studies that would otherwise not be possible,” said Rajeev Vibhakar, MD, PhD and Program Leader of Pediatric Neuro-Oncology at the University of Colorado School of Medicine and Children’s Hospital Colorado. “It is these studies that often lead to novel, groundbreaking research projects and subsequent therapeutic interventions.”

2023 Projects Funded

CDK12 links radiation response to PARPi sensitivity in glioma
Nathan Dahl

Combinatorial targeting of transcriptional processivity in DIPG
Nathan Dahl

Pilot of Cell-Free DNA Testing in a National Pediatric HGG Trial
Adam Green

Single cell CiteSeq proteomic characterization of ependymoma infiltrating immune cells
Nicholas Foreman, Andrew Donson

Developing Models and Comparative Oncology Data for Canine and Pediatric High-Grade Gliomas
Adam Green, Steven Dow

Pilot Investigation to Characterize the Response of ACP Culture Models to Hypoxia
Todd Hankinson

Chromosome 1q and 6q changes as drivers of ependymoma recurrence
Nicholas Foreman, Andrew Donson

Spatial transcriptomic analysis of childhood brain tumor medulloblastoma
Nicholas Foreman, Andrew Donson

NF1-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors: addressing MPNST tumor heterogeneity to identify novel therapy options
Nicholas Foreman

Omics “in the round”
Nicholas Foreman

Development of Chimeric Antigen Receptor expressing macrophages to target pediatric brain tumors
Siddhartha Mitra, Sujatha Venkataraman, Eric Kohler

Evaluation of frozen apheresis products for tumor cell contamination
Jean M. Mulcahy Levy, Anan Nellan, Siddhartha Mitra

Identify high affinity EFNA1 variants for immunotherapy against DIPG tumors that harbors wildtype histone H3
Sujatha Venkataraman, Siddhartha Mitra, Krishna Madhavan, Kristofer Fritz

Novel CAR-T cell therapies to circumvent the highly immunosuppressive ependymoma tumor microenvironment
Sujatha Venkataraman, Andrew Donson, Anandani Nellan, Andrea Griesinger, Nicholas Foreman

Continuing Investigation of Childhood Cancer Early Death and Its Potential Causes
Adam Green

Counterfactual Explanations of AI Predictions with Uncertainty to Improve Non-Invasive Diagnostic Accuracy of Pediatric Suprasellar Tumors
Todd Hankinson, Carsten Görg

Characterization of Cancer-associated Fibroblasts derived from Adamantinomatous Craniopharyngioma

Todd Hankinson

Piloting Key Correlative Studies in a National Pediatric HGG Trial
Adam Green

Spatial Transcriptomics in Pediatric High-Grade Glioma
Adam Green

Integrating single cell RNA sequencing with Visium data to identify the radiation resistance population of cells in DIPG tumors
Andrew Donson, Sujatha Venkataraman

IDH1 as a regulator of radiation resistance in Medulloblastoma
Bethany Veo, Rajeev Vibhakar

Regulation of Wnt by CDK11 in Myc medulloblastoma
Dong Wang, Rajeev Vibhakar

PARP inhibition in ATRT and Medulloblastoma
Irina Alimova, Breaunna Brunt, Rajeev Vibhakar

Single Nuclei Multiomics to identify mechanisms of oncogenesis in ATRT
Rajeev Vibhakar

Combinatorial targeting of CDK7 and antimetabolites for ATRT
Jean Mulcahy Levy

Rajeev Vibhakar

Targeting an Oncogenic Driver in Infant Acute Lymphoblastic Leukemia: Bedside to Bench Correlative Studies
Kelly Faulk, Patricia Ernst

Translating discoveries from brain tumor genomics into new therapeutic strategies
David Solomon

Determining selinexor/radiation markers of response and combination therapy in diffuse midline glioma
DIPG DMG Research Funding Alliance Round 1 Grant Funding

Adam Green

Targeting circadian regulation of epithelial-mesenchymal transition and tumor invasiveness in pediatric gliomas
DIPG DMG Research Funding Alliance Round 1 Grant Funding

Erin Gibson

Institutional Partners